Lessons Learned From 2 Patients With Multidrug-Resistant HIV-1 Infection Successfully Treated With a Darunavir-Containing Antiretroviral Treatment Regimen
Robert Colebunders, MD, PhD*,
Erika Vlieghe, MD,
Ula Maniewski, MD,
Tom Schepens,
Els Hollanders,
Eric Gheuens, MD, PhD,
and
Ann De Roo, MD
Institute of Tropical Medicine
* To whom correspondence should be addressed. E-mail: bcoleb{at}itg.be.
 |
Abstract |
|---|
The authors describe 2 patients with life-threatening multidrug-resistant HIV-1 infection who responded very well to a treatment regimen containing darunavir and enfuvirtide. They discuss the availability of several new treatment options such as darunavir, etravirine, integrase, and CCR5 inhibitors for patients with multidrug-resistant viruses.
